✦ LIBER ✦
Requiring a CSF amyloid-β42 biomarker for a prodromal AD research diagnosis does not result in better clinical trials: Simulations from the ADNI database
✍ Scribed by Lon S. Schneider; Richard E. Kennedy; Gary R. Cutter
- Book ID
- 118466097
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 43 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1552-5260
No coin nor oath required. For personal study only.